Literature DB >> 7559469

Role of N-linked glycosylation in human osteonectin. Effect of carbohydrate removal by N-glycanase and site-directed mutagenesis on structure and binding of type V collagen.

R L Xie1, G L Long.   

Abstract

In this study we demonstrate that the binding region of recombinant truncated human bone osteonectin (tHON) for type V collagen resides between amino acids 1 and 146. After removal of oligosaccharide chain structures from tHON, bovine bone osteonectin (BBON) and human platelet osteonectin (HPON) by N-glycanase, their ability to bind to type V collagen is increased, and HPON affinity to collagen V is the same as that of BBON. These data suggest that glycosylation of osteonectin has a direct or regulatory effect on osteonectin binding to collagen V and that the increase in tHON binding upon removal of carbohydrate is the result of a loss of a down-regulation site or direct interference of the carbohydrate at the binding site. To determine the specific role of each N-glycosylation site in tHON, Asn71 and Asn99 were mutated to Gln (N71Q, N99Q) and Thr73 and Thr101 mutated to Ala (T73A, T101A) to selectively inhibit oligosaccharide attachment. The binding affinity of N99Q and T101Q to collagen V is markedly increased over wild-type tHON, whereas N71Q and T73A are the same as wild-type tHON. The doubled mutant (N71,99Q) binds identically to collagen V as N99Q and T101A. These data suggest that only the position 99 glycosylation site (Asn99-X-Thr101) in tHON is important in the reduction of binding of osteonectin to collagen V. Consistent with the binding data is the observation that both the N71Q and T73A mutant proteins migrate on SDS-polyacrylamide gel electrophoresis gels identically to wild-type tHON, suggesting that there is little or no N-glycosylation of residue 71 in wild-type osteonectin.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7559469     DOI: 10.1074/jbc.270.39.23212

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Mapping of SPARC/BM-40/osteonectin-binding sites on fibrillar collagens.

Authors:  Camilla Giudici; Nicolas Raynal; Hanna Wiedemann; Wayne A Cabral; Joan C Marini; Rupert Timpl; Hans Peter Bächinger; Richard W Farndale; Takako Sasaki; Ruggero Tenni
Journal:  J Biol Chem       Date:  2008-05-16       Impact factor: 5.157

2.  Crystal structure of a pair of follistatin-like and EF-hand calcium-binding domains in BM-40.

Authors:  E Hohenester; P Maurer; R Timpl
Journal:  EMBO J       Date:  1997-07-01       Impact factor: 11.598

Review 3.  Anti-cancer role of SPARC, an inhibitor of adipogenesis.

Authors:  Ganji Purna Chandra Nagaraju; Dipali Sharma
Journal:  Cancer Treat Rev       Date:  2011-01-14       Impact factor: 12.111

Review 4.  The role of SPARC (secreted protein acidic and rich in cysteine) in the pathogenesis of obesity, type 2 diabetes, and non-alcoholic fatty liver disease.

Authors:  Catalina Atorrasagasti; Agostina M Onorato; Guillermo Mazzolini
Journal:  J Physiol Biochem       Date:  2022-08-26       Impact factor: 5.080

5.  Revealing Glycoproteins in the Secretome of MCF-7 Human Breast Cancer Cells.

Authors:  Aik-Aun Tan; Wai-Mei Phang; Subash C B Gopinath; Onn H Hashim; Lik Voon Kiew; Yeng Chen
Journal:  Biomed Res Int       Date:  2015-06-17       Impact factor: 3.411

Review 6.  Dissecting the conformation of glycans and their interactions with proteins.

Authors:  Sheng-Hung Wang; Tsai-Jung Wu; Chien-Wei Lee; John Yu
Journal:  J Biomed Sci       Date:  2020-09-09       Impact factor: 8.410

7.  Prognostic value of SPARC in hepatocellular carcinoma: A systematic review and meta-analysis.

Authors:  Xiaoyu Yang; Yunhong Xia; Shuomin Wang; Chen Sun
Journal:  PLoS One       Date:  2022-08-18       Impact factor: 3.752

8.  Structural basis of sequence-specific collagen recognition by SPARC.

Authors:  Erhard Hohenester; Takako Sasaki; Camilla Giudici; Richard W Farndale; Hans Peter Bächinger
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-14       Impact factor: 11.205

9.  Expression of Secreted Protein Acidic and Rich in Cysteine in the Stroma of a Colorectal Carcinoma is Associated With Patient Prognosis.

Authors:  Jeong Yeon Kim; Dongjun Jeong; Tae Sung Ahn; Hyung Ju Kim; Doo San Park; So Yong Park; Sang Byung Bae; Sookyoung Lee; Sung Soo Lee; Moon Soo Lee; Hyun Deuk Cho; Moo Jun Baek
Journal:  Ann Coloproctol       Date:  2013-06-30

10.  Comparative secretomic and N-glycoproteomic profiling in human MCF-7 breast cancer and HMEpC normal epithelial cell lines using a gel-based strategy.

Authors:  Aik-Aun Tan; Alan Kang-Wai Mu; Lik-Voon Kiew; Yeng Chen
Journal:  Cancer Cell Int       Date:  2014-11-30       Impact factor: 5.722

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.